Analgesics - Kuwait

  • Kuwait
  • In Kuwait, the revenue generated in the Analgesics market is estimated to reach US$93.84m in 2024.
  • It is projected to experience an annual growth rate of 4.11% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, amounting to US$7,243.00m in 2024.
  • In terms of per capita figures, each person in Kuwait contributes approximately US$21.58 in revenue in 2024.
  • Kuwait's growing demand for OTC analgesics reflects a shift towards self-medication and increased awareness of pain management.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Kuwait is experiencing significant growth due to various factors.

Customer preferences:
Customers in Kuwait have shown a growing preference for analgesics as a means to alleviate pain and discomfort. This can be attributed to the increasing awareness about the benefits of analgesics and the availability of a wide range of products in the market. Customers are also becoming more health-conscious and are seeking immediate relief from pain, which has further fueled the demand for analgesics.

Trends in the market:
One of the key trends in the Analgesics market in Kuwait is the shift towards natural and herbal remedies. Customers are increasingly opting for products that are perceived to be more natural and have fewer side effects. This trend is driven by the growing awareness about the potential risks associated with long-term use of conventional analgesics. As a result, manufacturers are introducing a range of natural and herbal analgesics to cater to this demand. Another trend in the market is the increasing availability of analgesics through online channels. Customers in Kuwait are increasingly turning to online platforms to purchase analgesics due to the convenience and ease of access. Online platforms also offer a wider range of products and competitive pricing, which has further contributed to their popularity.

Local special circumstances:
Kuwait has a high prevalence of chronic diseases such as diabetes and cardiovascular diseases, which often require long-term pain management. This has created a significant demand for analgesics in the country. Additionally, the aging population in Kuwait is also contributing to the growth of the analgesics market, as older individuals are more likely to experience chronic pain and require pain management solutions.

Underlying macroeconomic factors:
The growing economy of Kuwait has played a significant role in the development of the analgesics market. With increasing disposable incomes, customers have more purchasing power and are willing to spend on healthcare products, including analgesics. Additionally, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also contributed to the growth of the analgesics market. In conclusion, the Analgesics market in Kuwait is witnessing growth due to the increasing customer preference for pain relief solutions, the shift towards natural and herbal remedies, the availability of analgesics through online channels, the high prevalence of chronic diseases, the aging population, and the growing economy. These factors are driving the demand for analgesics in Kuwait and are expected to continue to fuel the market's growth in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)